Psychiatry and Neurology, Neurology · Downey, CA
NPI
1952319253
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
11525 Brookshire Ave Ste 205
Downey, CA, 90241
Phone (562) 861-1988
Groups this clinician bills Medicare through
Medicare paid, 2024
$436K
5,129 services
Medicare patients, 2024
736
Average age 68
Drug cost, 2024
$1.3M
11,926 prescriptions
Company payments, 2025
$6,636
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Munther A Hijazin was code 99232 (hospital e&m - subsequent), 2,910 times for 124 patients. In total Munther A Hijazin billed 5,129 services in 17 codes, and Medicare paid $436K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-04-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,910 | 124 | $58.67 | $171K |
| 99214 Office E&M - Established | Office | 1,018 | 511 | $72.51 | $74K |
| 95816 Neurologic | Office | 432 | 425 | $276.02 | $119K |
| 99204 Office E&M - New | Office | 211 | 211 | $111.05 | $23K |
| 99223 Hospital E&M - Initial | Facility | 127 | 123 | $129.57 | $16K |
| 95819 Neurologic | Facility | 125 | 105 | $42.75 | $5,344 |
| 95886 Electrical Nerve Conductivity | Office | 74 | 69 | $76.55 | $5,665 |
| 96116 Behavioral Health Services | Office | 63 | 63 | $70.39 | $4,434 |
| 95911 Electrical Nerve Conductivity | Office | 39 | 39 | $168.58 | $6,575 |
| 95910 Electrical Nerve Conductivity | Office | 35 | 35 | $137.69 | $4,819 |
| 95977 Electrical Nerve Conductivity | Office | 29 | 13 | $38.13 | $1,106 |
By year: 2022 $373K for 3,999 services; 2023 $406K for 4,061 services; 2024 $436K for 5,129 services.
Medicare prescription drug claims, 2024
In 2024, the drug Munther A Hijazin prescribed most often to Medicare patients was Memantine Hcl, with 2,260 prescriptions and refills. In total Munther A Hijazin wrote 11,926 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 2,260 | 2,635 | 419 | $37K |
| Gabapentin Generic | 1,105 | 1,205 | 255 | $10K |
| Levetiracetam Generic | 873 | 1,353 | 161 | $28K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 784 | 1,235 | 148 | $15K |
| Donepezil Hcl Generic | 356 | 624 | 79 | $2,751 |
| Pregabalin Generic | 350 | 370 | 95 | $6,083 |
| Topiramate Generic | 296 | 376 | 42 | $4,408 |
| Phenytoin Sodium Extended Generic | 280 | 407 | 48 | $8,574 |
| Quetiapine Fumarate Generic | 271 | 306 | 51 | $4,171 |
| Nortriptyline Hcl Generic | 265 | 300 | 56 | $2,087 |
| Carbamazepine Generic | 248 | 378 | 42 | $14K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 220 | 325 | 38 | $3,334 |
| Clonazepam Generic | 202 | 206 | 36 | $706 |
| Meloxicam Generic | 201 | 204 | 46 | $376 |
| Oxcarbazepine Generic | 198 | 243 | 24 | $8,981 |
Brand drugs: 617 claims; generic drugs: 11,132 claims; opioid claims: 125.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Munther A Hijazin $6,636 ($6,636 in general payments such as food, travel and fees) from 29 companies. The largest payer was UCB, Inc. with $1,075.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 36 | $1,075 |
| SK Life Science, Inc. | 64 | $698 |
| Abbvie Inc. ABBV | 44 | $543 |
| LivaNova USA, Inc. LIVN | 85 | $516 |
| Novartis Pharmaceuticals Corporation NVS | 34 | $442 |
| Teva Pharmaceuticals USA, Inc. TEVA | 17 | $410 |
| EMD Serono, Inc. MRK.DE | 21 | $381 |
| Neurocrine BioSciences, Inc. NBIX | 16 | $323 |
| Neurelis, Inc. | 21 | $301 |
| Alexion Pharmaceuticals, Inc. AZN | 11 | $284 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.